PMC:7283670 / 48783-49546 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T170","span":{"begin":132,"end":138},"obj":"Body_part"}],"attributes":[{"id":"A170","pred":"fma_id","subj":"T170","obj":"http://purl.org/sig/ont/fma/fma228738"}],"text":"Lan et al. (2020), China Case study/Zhongnan Hospital of Wuhan University, Wuhan 4, 30–36 years, 2 male RT‐PCR, thin‐section CT Throat swabs Medical personnel quarantined at home with COVID‐19 Spectrum of disease: mild to moderate\nResults: (at admission); PCR positive: for all CT positive: for all GGO, or mixed GGO/consolidation\n(after therapy); 2 consecutive negative RT‐PCR: all (after discharge); repeated RT‐PCR 5–13 days later: all positive Fever:3, cough: 3, both: 3 Symptom onset to recovery: 12–32 days – Therapy: antiviral treatment (75 mg of oseltamivir every 12 hr)\nResolved clinical symptoms and CT abnormalities: 3\nDelicate patches of GGO: 1\nInterpretation: possibility of at least a proportion of recovered patients act as virus carriers"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T116","span":{"begin":132,"end":138},"obj":"Body_part"}],"attributes":[{"id":"A116","pred":"uberon_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/UBERON_0000341"}],"text":"Lan et al. (2020), China Case study/Zhongnan Hospital of Wuhan University, Wuhan 4, 30–36 years, 2 male RT‐PCR, thin‐section CT Throat swabs Medical personnel quarantined at home with COVID‐19 Spectrum of disease: mild to moderate\nResults: (at admission); PCR positive: for all CT positive: for all GGO, or mixed GGO/consolidation\n(after therapy); 2 consecutive negative RT‐PCR: all (after discharge); repeated RT‐PCR 5–13 days later: all positive Fever:3, cough: 3, both: 3 Symptom onset to recovery: 12–32 days – Therapy: antiviral treatment (75 mg of oseltamivir every 12 hr)\nResolved clinical symptoms and CT abnormalities: 3\nDelicate patches of GGO: 1\nInterpretation: possibility of at least a proportion of recovered patients act as virus carriers"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T292","span":{"begin":189,"end":197},"obj":"Disease"}],"attributes":[{"id":"A292","pred":"mondo_id","subj":"T292","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Lan et al. (2020), China Case study/Zhongnan Hospital of Wuhan University, Wuhan 4, 30–36 years, 2 male RT‐PCR, thin‐section CT Throat swabs Medical personnel quarantined at home with COVID‐19 Spectrum of disease: mild to moderate\nResults: (at admission); PCR positive: for all CT positive: for all GGO, or mixed GGO/consolidation\n(after therapy); 2 consecutive negative RT‐PCR: all (after discharge); repeated RT‐PCR 5–13 days later: all positive Fever:3, cough: 3, both: 3 Symptom onset to recovery: 12–32 days – Therapy: antiviral treatment (75 mg of oseltamivir every 12 hr)\nResolved clinical symptoms and CT abnormalities: 3\nDelicate patches of GGO: 1\nInterpretation: possibility of at least a proportion of recovered patients act as virus carriers"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T488","span":{"begin":89,"end":91},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T489","span":{"begin":101,"end":105},"obj":"http://purl.obolibrary.org/obo/UBERON_0003101"},{"id":"T490","span":{"begin":101,"end":105},"obj":"http://www.ebi.ac.uk/efo/EFO_0000970"},{"id":"T491","span":{"begin":707,"end":708},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T492","span":{"begin":749,"end":754},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"Lan et al. (2020), China Case study/Zhongnan Hospital of Wuhan University, Wuhan 4, 30–36 years, 2 male RT‐PCR, thin‐section CT Throat swabs Medical personnel quarantined at home with COVID‐19 Spectrum of disease: mild to moderate\nResults: (at admission); PCR positive: for all CT positive: for all GGO, or mixed GGO/consolidation\n(after therapy); 2 consecutive negative RT‐PCR: all (after discharge); repeated RT‐PCR 5–13 days later: all positive Fever:3, cough: 3, both: 3 Symptom onset to recovery: 12–32 days – Therapy: antiviral treatment (75 mg of oseltamivir every 12 hr)\nResolved clinical symptoms and CT abnormalities: 3\nDelicate patches of GGO: 1\nInterpretation: possibility of at least a proportion of recovered patients act as virus carriers"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T142","span":{"begin":101,"end":105},"obj":"Chemical"},{"id":"T143","span":{"begin":534,"end":543},"obj":"Chemical"},{"id":"T144","span":{"begin":564,"end":575},"obj":"Chemical"},{"id":"T145","span":{"begin":755,"end":763},"obj":"Chemical"}],"attributes":[{"id":"A142","pred":"chebi_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/CHEBI_30780"},{"id":"A143","pred":"chebi_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A144","pred":"chebi_id","subj":"T144","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A145","pred":"chebi_id","subj":"T145","obj":"http://purl.obolibrary.org/obo/CHEBI_78059"}],"text":"Lan et al. (2020), China Case study/Zhongnan Hospital of Wuhan University, Wuhan 4, 30–36 years, 2 male RT‐PCR, thin‐section CT Throat swabs Medical personnel quarantined at home with COVID‐19 Spectrum of disease: mild to moderate\nResults: (at admission); PCR positive: for all CT positive: for all GGO, or mixed GGO/consolidation\n(after therapy); 2 consecutive negative RT‐PCR: all (after discharge); repeated RT‐PCR 5–13 days later: all positive Fever:3, cough: 3, both: 3 Symptom onset to recovery: 12–32 days – Therapy: antiviral treatment (75 mg of oseltamivir every 12 hr)\nResolved clinical symptoms and CT abnormalities: 3\nDelicate patches of GGO: 1\nInterpretation: possibility of at least a proportion of recovered patients act as virus carriers"}

{"project":"LitCovid-sentences","denotations":[{"id":"T539","span":{"begin":0,"end":236},"obj":"Sentence"},{"id":"T540","span":{"begin":237,"end":336},"obj":"Sentence"},{"id":"T541","span":{"begin":337,"end":470},"obj":"Sentence"},{"id":"T542","span":{"begin":471,"end":479},"obj":"Sentence"},{"id":"T543","span":{"begin":480,"end":509},"obj":"Sentence"},{"id":"T544","span":{"begin":510,"end":588},"obj":"Sentence"},{"id":"T545","span":{"begin":589,"end":637},"obj":"Sentence"},{"id":"T546","span":{"begin":638,"end":639},"obj":"Sentence"},{"id":"T547","span":{"begin":640,"end":664},"obj":"Sentence"},{"id":"T548","span":{"begin":665,"end":666},"obj":"Sentence"},{"id":"T549","span":{"begin":667,"end":763},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Lan et al. (2020), China Case study/Zhongnan Hospital of Wuhan University, Wuhan 4, 30–36 years, 2 male RT‐PCR, thin‐section CT Throat swabs Medical personnel quarantined at home with COVID‐19 Spectrum of disease: mild to moderate\nResults: (at admission); PCR positive: for all CT positive: for all GGO, or mixed GGO/consolidation\n(after therapy); 2 consecutive negative RT‐PCR: all (after discharge); repeated RT‐PCR 5–13 days later: all positive Fever:3, cough: 3, both: 3 Symptom onset to recovery: 12–32 days – Therapy: antiviral treatment (75 mg of oseltamivir every 12 hr)\nResolved clinical symptoms and CT abnormalities: 3\nDelicate patches of GGO: 1\nInterpretation: possibility of at least a proportion of recovered patients act as virus carriers"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T185","span":{"begin":455,"end":460},"obj":"Phenotype"},{"id":"T186","span":{"begin":464,"end":469},"obj":"Phenotype"}],"attributes":[{"id":"A185","pred":"hp_id","subj":"T185","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A186","pred":"hp_id","subj":"T186","obj":"http://purl.obolibrary.org/obo/HP_0012735"}],"text":"Lan et al. (2020), China Case study/Zhongnan Hospital of Wuhan University, Wuhan 4, 30–36 years, 2 male RT‐PCR, thin‐section CT Throat swabs Medical personnel quarantined at home with COVID‐19 Spectrum of disease: mild to moderate\nResults: (at admission); PCR positive: for all CT positive: for all GGO, or mixed GGO/consolidation\n(after therapy); 2 consecutive negative RT‐PCR: all (after discharge); repeated RT‐PCR 5–13 days later: all positive Fever:3, cough: 3, both: 3 Symptom onset to recovery: 12–32 days – Therapy: antiviral treatment (75 mg of oseltamivir every 12 hr)\nResolved clinical symptoms and CT abnormalities: 3\nDelicate patches of GGO: 1\nInterpretation: possibility of at least a proportion of recovered patients act as virus carriers"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1182","span":{"begin":733,"end":741},"obj":"Species"},{"id":"1382","span":{"begin":189,"end":197},"obj":"Disease"},{"id":"1383","span":{"begin":455,"end":460},"obj":"Disease"},{"id":"1384","span":{"begin":464,"end":469},"obj":"Disease"}],"attributes":[{"id":"A1182","pred":"tao:has_database_id","subj":"1182","obj":"Tax:9606"},{"id":"A1382","pred":"tao:has_database_id","subj":"1382","obj":"MESH:C000657245"},{"id":"A1383","pred":"tao:has_database_id","subj":"1383","obj":"MESH:D005334"},{"id":"A1384","pred":"tao:has_database_id","subj":"1384","obj":"MESH:D003371"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Lan et al. (2020), China Case study/Zhongnan Hospital of Wuhan University, Wuhan 4, 30–36 years, 2 male RT‐PCR, thin‐section CT Throat swabs Medical personnel quarantined at home with COVID‐19 Spectrum of disease: mild to moderate\nResults: (at admission); PCR positive: for all CT positive: for all GGO, or mixed GGO/consolidation\n(after therapy); 2 consecutive negative RT‐PCR: all (after discharge); repeated RT‐PCR 5–13 days later: all positive Fever:3, cough: 3, both: 3 Symptom onset to recovery: 12–32 days – Therapy: antiviral treatment (75 mg of oseltamivir every 12 hr)\nResolved clinical symptoms and CT abnormalities: 3\nDelicate patches of GGO: 1\nInterpretation: possibility of at least a proportion of recovered patients act as virus carriers"}